Skip to content
Screener

Zymeworks ZYME Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$2.4MMiss by $22.0M
EPS-$0.59Miss by $0.49
Revenue estimate$24.4M
EPS estimate-$0.10

Next report

Nov 5, 2026 (In 3 weeks)
Revenue estimate$227.4M
EPS estimate$2.29

Financials

Q1 2026

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.86B+125%
Enterprise value$1.63B+112%
P/S22.9×+14.0×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

FAQ

When did Zymeworks report Q1 2026 earnings?
Zymeworks (ZYME) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Zymeworks's Q1 2026 revenue and EPS?
Zymeworks reported revenue of $2.4M and eps of $-0.59 for Q1 2026.
Did Zymeworks beat estimates in Q1 2026?
Revenue missed the consensus estimate of $24.4M by $22.0M. EPS missed the consensus estimate of $-0.10 by $0.49.
How did Zymeworks's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 91.1% from $27.1M a year earlier and eps declined 96.7% from $-0.30.
Where can I find Zymeworks's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001937653-26-000033) and the 10-Q periodic report (0001937653-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.